Price Alert

Nautilus Biotechnology In... (NAUT)

NASDAQ: NAUT · Real-Time Price · USD

1.07

-0.03 (-2.73%)

At close: Oct 16, 2025, 3:59 PM

1.02

-4.67%

After-hours: Oct 16, 2025, 07:15 PM EDT

-2.73% (1D)

Bid	1.03
Market Cap	135.15M
Revenue (ttm)	9.6M
Net Income (ttm)	-65.69M
EPS (ttm)	-0.52
PE Ratio (ttm)	-2.06
Forward PE	-1.43
Analyst	Sell
Dividends	n/a

Ask	1.33
Volume	749,147
Avg. Volume (20D)	281,332
Open	1.11
Previous Close	1.10
Day's Range	1.04 - 1.24
52-Week Range	0.62 - 2.99
Beta	1.33
Ex-Dividend Date	n/a

About NAUT

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol NAUT

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NAUT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

7 months ago

-18.18%

Nautilus Biotechnology shares are trading lower. T... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

Nautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:50 PM EDT Company Participants Sujal Patel - Co-Founder, CEO, President, Secreta...

2 months ago · seekingalpha.com

Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2025 Earnings Call July 31, 2025 8:30 AM ET Company Participants Anna Mowry - CFO & Treasurer Parag Mallick - Co-Founder, Chief Scientist & Director Suja...